Gliom: Genetische Risikobewertung
Über den Vortrag
Der Vortrag „Gliom: Genetische Risikobewertung“ von Roy Strowd, MD ist Bestandteil des Kurses „ZNS-Tumore“.
Quiz zum Vortrag
Which of the following genes is most commonly mutated in all cancer types and can be seen in astrocytomas?
- TP53
- 1p19q codeletion
- p16
- DPC
- WT1
[Select all that apply] Genetic testing is important in gliomas because it helps to determine ...
- ... how tumors will act (i.e., their behavior).
- ... whether the tumor has metastasized from another organ.
- ... the prognosis.
- ... the best treatment.
- ... the embryologic cell type.
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Gliom: Genetische Risikobewertung
Roy Strowd, MD
Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
